KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Capital Expenditures: 2010-2025

Historic Capital Expenditures for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to $1.2 million.

  • Dynavax Technologies' Capital Expenditures fell 8.10% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year increase of 119.60%. This contributed to the annual value of $6.4 million for FY2024, which is 54.78% up from last year.
  • As of Q3 2025, Dynavax Technologies' Capital Expenditures stood at $1.2 million, which was down 14.81% from $1.5 million recorded in Q2 2025.
  • Dynavax Technologies' Capital Expenditures' 5-year high stood at $3.9 million during Q1 2025, with a 5-year trough of $347,000 in Q3 2023.
  • In the last 3 years, Dynavax Technologies' Capital Expenditures had a median value of $1.3 million in 2023 and averaged $1.6 million.
  • In the last 5 years, Dynavax Technologies' Capital Expenditures surged by 1,269.43% in 2021 and then slumped by 72.91% in 2023.
  • Dynavax Technologies' Capital Expenditures (Quarterly) stood at $3.0 million in 2021, then plummeted by 47.73% to $1.6 million in 2022, then grew by 8.57% to $1.7 million in 2023, then skyrocketed by 101.86% to $3.5 million in 2024, then fell by 8.10% to $1.2 million in 2025.
  • Its Capital Expenditures was $1.2 million in Q3 2025, compared to $1.5 million in Q2 2025 and $3.9 million in Q1 2025.